Extended producer responsibility

Extended Producer Responsibility (EPR) is a policy approach that holds manufacturers accountable for the entire lifecycle of their products, including post-consumer waste management. In pharmaceutics, EPR is gaining importance as environmental concerns surrounding pharmaceutical waste, packaging, and plastic use grow. Under EPR frameworks, pharmaceutical companies are increasingly expected to take responsibility for the collection, disposal, and potential recycling of unused medications, expired drugs, and associated packaging. This helps prevent improper disposal, which can lead to environmental contamination, including the presence of pharmaceutical residues in water bodies that pose risks to aquatic ecosystems and public health. Implementing EPR also encourages the design of eco-friendly packaging and the reduction of single-use plastics commonly used in blister packs, syringes, and containers.

From an industry standpoint, EPR supports a more sustainable and circular pharmaceutical supply chain. Companies are now integrating take-back programs, green chemistry principles, and environmentally conscious design to minimize their environmental footprint. In doing so, they also meet growing consumer and regulatory expectations for corporate environmental responsibility. Governments in several countries are introducing mandatory EPR regulations for pharmaceuticals, making compliance essential. As sustainability becomes central to the pharmaceutical sector's long-term strategy, embracing EPR allows companies to align innovation with environmental stewardship, reduce waste, and contribute to global health and ecological preservation.